InfuSystem reports Q2 2026 revenue of $36.9M and $8.6M adjusted EBITDA
InfuSystem recorded 2.6% revenue growth despite a device solution decline, highlighting corporate outsourced revenue restructuring and product diversification.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day